Intracerebroventricular infusion of the CCKB receptor agonist pentagastrin potentiates acoustic startle.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 8891258)

Published in Brain Res on September 09, 1996

Authors

P W Frankland1, S A Josselyn, J Bradwejn, F J Vaccarino, J S Yeomans

Author Affiliations

1: Department of Psychology, University of Toronto, Ont., Canada.

Articles by these authors

Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry (2001) 3.18

International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev (1999) 1.74

Computer-assisted behavioral assessment of Pavlovian fear conditioning in mice. Learn Mem (2000) 1.61

Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. Am J Psychiatry (1995) 1.59

Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology (Berl) (2001) 1.58

Tardive dyskinesia: legal and preventive aspects. Can J Psychiatry (1990) 1.47

Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers. Am J Psychiatry (1993) 1.40

A portrait of the substrate for self-stimulation. Psychol Rev (1981) 1.30

The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacol Biochem Behav (1986) 1.06

Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities. J Psychiatry Neurosci (1996) 1.03

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones. Nature (1984) 0.98

Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology (Berl) (1985) 0.95

Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat. Neuroscience (2005) 0.95

Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol Psychiatry (1999) 0.94

CCK in animal and human research on anxiety. Trends Pharmacol Sci (1993) 0.94

Emerging roles for MEF2 transcription factors in memory. Genes Brain Behav (2013) 0.93

Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus. Neuroscience (1997) 0.93

A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Can J Psychiatry (1997) 0.92

Median raphe injections of 8-OH-DPAT lower frequency thresholds for lateral hypothalamic self-stimulation. Pharmacol Biochem Behav (1995) 0.92

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin. Depress Anxiety (2012) 0.91

Role of the laterodorsal tegmental nucleus in scopolamine- and amphetamine-induced locomotion and stereotypy. Pharmacol Biochem Behav (2000) 0.91

Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans. Neuropsychopharmacology (1999) 0.91

Cholinergic involvement in lateral hypothalamic rewarding brain stimulation. Brain Res (1985) 0.90

Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry (1999) 0.89

Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat. J Neurosci (1997) 0.89

Amphetamine- and morphine-induced feeding: evidence for involvement of reward mechanisms. Neurosci Biobehav Rev (1990) 0.89

Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Psychiatry Neurosci (1997) 0.88

Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacol Biochem Behav (1986) 0.87

Self-administration of intravenous amphetamine is predicted by individual differences in sucrose feeding in rats. Psychopharmacology (Berl) (2000) 0.87

Cholecystokinergic innervation of nucleus accumbens subregions. Peptides (1998) 0.87

Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Depress Anxiety (1998) 0.87

The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms. Biol Psychiatry (1998) 0.87

Central somatostatin: a re-examination of its effects on feeding. Brain Res (1990) 0.86

Intra-nucleus accumbens amphetamine: dose-dependent effects on food intake. Pharmacol Biochem Behav (1986) 0.85

Neurochemical substrates for opiate reinforcement. NIDA Res Monogr (1986) 0.85

Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers. Eur Neuropsychopharmacol (1991) 0.85

Neurobiology of panic disorder. J Psychosom Res (1998) 0.84

A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study. Psychopharmacology (Berl) (1992) 0.84

Locomotion and stereotypy induced by scopolamine: contributions of muscarinic receptors near the pedunculopontine tegmental nucleus. Brain Res (1997) 0.84

Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration. Pharmacol Biochem Behav (1988) 0.84

Prepulse inhibition of acoustic or trigeminal startle of rats by unilateral electrical stimulation of the inferior colliculus. Behav Neurosci (1998) 0.84

Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity. J Psychiatry Neurosci (1991) 0.83

Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers. Biol Psychiatry (1996) 0.82

Facilitation and inhibition of feeding by a single dose of amphetamine: relationship to baseline intake and accumbens cholecystokinin. Psychopharmacology (Berl) (1991) 0.81

Individual differences in sugar consumption following systemic or intraaccumbens administration of low doses of amphetamine in nondeprived rats. Pharmacol Biochem Behav (1996) 0.81

Effects of d- and l-amphetamine on food intake: evidence for a dopaminergic substrate. Pharmacol Biochem Behav (1987) 0.81

Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat. Pharmacol Biochem Behav (1985) 0.81

Contributions of the vestibular nucleus and vestibulospinal tract to the startle reflex. Neuroscience (2001) 0.81

Summation between acoustic and trigeminal stimuli evoking startle. Neuroscience (1999) 0.80

The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4. J Psychosom Res (2001) 0.80

Evidence for a common neural mechanism mediating growth hormone-releasing factor-induced and somatostatin-induced feeding. Neuroendocrinology (1993) 0.80

Effects of intracerebroventricular administration of methyl naloxonium chloride on heroin self-administration in the rat. Pharmacol Biochem Behav (1985) 0.80

High neuroleptic plasma levels in patients manifesting supersensitivity psychosis. Biol Psychiatry (1982) 0.79

Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. Am J Psychiatry (1992) 0.79

Low plasma cortisol in bulimia nervosa patients with reversed neurovegetative symptoms of depression. Biol Psychiatry (1997) 0.79

CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects. Eur Neuropsychopharmacol (1999) 0.79

Effects of bilateral electrical stimulation of the ventral pallidum on acoustic startle. Brain Res (1999) 0.79

Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur Neuropsychopharmacol (1995) 0.79

Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J Psychiatry Neurosci (1992) 0.79

Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.79

Growth hormone-regulatory peptides (GHRH and somatostatin) and feeding: a model for the integration of central and peripheral function. Neurosci Biobehav Rev (1994) 0.79

Hormonal and subjective responses to intravenous m-chlorophenylpiperazine in women with seasonal affective disorder. Arch Gen Psychiatry (1998) 0.79

Development of a sensitive and specific assay system for cholecystokinin tetrapeptide. Peptides (1997) 0.79

The absolute refractory periods of self-stimulation neurons. Physiol Behav (1979) 0.79

Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward. Neurosci Lett (1984) 0.79

MMPI profiles of acute and chronic PTSD in a civilian sample. J Trauma Stress (1996) 0.79

Two converging brainstem pathways mediating circling behavior. Brain Res (1986) 0.78

Effects of CCK-4 infusion on the acoustic eye-blink startle and psychophysiological measures in healthy volunteers. J Psychopharmacol (1999) 0.78

Using intracranial electrical stimulation to study the timing of prepulse inhibition of the startle reflex. Brain Res Brain Res Protoc (2000) 0.78

Effect of aging on cholecystokinin-induced panic. Am J Psychiatry (1998) 0.78

The CCKB antagonist, L-365,260, attenuates fear-potentiated startle. Peptides (1995) 0.78

Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. Neuroreport (1995) 0.78

A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder. Psychol Med (2010) 0.78

Fear-potentiated startle and electrically evoked startle mediated by synapses in rostrolateral midbrain. Behav Neurosci (1995) 0.78

Differential effects of atropine, procaine and dopamine in the rat ventral tegmentum on lateral hypothalamic rewarding brain stimulation. Behav Brain Res (1990) 0.78

Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug. Can Med Assoc J (1982) 0.78

Individual differences in sugar intake predict the locomotor response to acute and repeated amphetamine administration. Psychopharmacology (Berl) (1994) 0.78

Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion. Pharmacol Biochem Behav (1994) 0.78

Subdiaphragmatic vagotomy does not prevent the anti-exploratory effect of caerulein in the elevated plus-maze. Neuropeptides (1994) 0.78

Neurobiology of panic disorder. Am J Psychiatry (1989) 0.78

Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy. CNS Drugs (1997) 0.77

An early phase II clinical trial of tomoxetine (LY139603) in the treatment of newly admitted depressed patients. Psychopharmacology (Berl) (1984) 0.77

An uncrossed tectopontine pathway mediates ipsiversive circling. Behav Brain Res (1993) 0.77

An early Phase II clinical trial with followup of tomoxetine (LY139603) in the treatment of newly admitted depressed patients. Psychopharmacol Bull (1985) 0.77

The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers. Biol Psychiatry (1997) 0.77

A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. J Affect Disord (1994) 0.77

Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze. Neuropharmacology (1994) 0.77

Cholinergic antagonists in ventral tegmentum elevate thresholds for lateral hypothalamic and brainstem self-stimulation. Pharmacol Biochem Behav (1988) 0.77

Cochlear and trigeminal systems contributing to the startle reflex in rats. Neuroscience (1999) 0.77

Effects of PK 8165, a partial benzodiazepine receptor agonist, on cholecystokinin-induced activation of hippocampal pyramidal neurons: a microiontophoretic study in the rat. Eur J Pharmacol (1985) 0.77

Comparative studies on the efficacy of psychotherapy, pharmacotherapy, and their combination in depression: was adequate pharmacotherapy provided? J Clin Psychopharmacol (1989) 0.77

Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.77